M Rizell, R Hultborn, P Bernhardt, J Svensson, M Sternby Eilard, O ...

More documents

Recommendations

Info

Appendix 3 Ref nr Study Sato KT (Radiology,2008) Schultz CC (Cancer Bio Radio,2009) Stubbs RS (J Gastroint Surg,2001) Townsend A (Cochrane Database Syst Rev,2009) Reason for exclusion Heterogeneous study groups with different diagnoses Does not fulfil PICO-criteria Data presented in included article (Stubbs RS et al. ANZ J Surg,2006 Reviewed SU/HTA-centre 2009-09-14
Sahlgrenska Universitetssjukhuset, HTA-centrum Röda Stråket 8, 413 45 Göteborg www.sahlgrenska.se/hta-centrum
Page 1 and 2: Health Technology Assessment HTA-ra
Page 3 and 4: Quality assurance process External
Page 5 and 6: Utlåtande och sammanfattande bedö
Page 7 and 8: Levermetastaser från kolorektal ca
Page 9 and 10: Question at issue: Does treatment w
Page 11 and 12: Which health technology or method w
Page 13 and 14: Both of these treatments for HCC ha
Page 15 and 16: locally administered treatment is t
Page 17 and 18: The reporting of adverse effects an
Page 19 and 20: Ethical aspects 7a. Ethical consequ
Page 21 and 22: Economy 9a. Present costs of curren
Page 23 and 24: assumed that this treatment would b
Page 25 and 26: Summary of the Health Technology As
Page 27 and 28: APPENDIX 1 - SEARCH STRATEGY, STUDY
Page 29 and 30: CRD 2009-12-16 Yttrium OR SIR-spher
Page 31 and 32: References Included studies: Hepato
Page 33 and 34: Kennedy AS, Coldwell D, Nutting C,
Page 35 and 36: Sangro B, Gil-Alzugaray B, Rodrigue
Page 37 and 38: Table 1a. Hepatocellular carcinoma
Page 39 and 40: Table 1b. Hepatocellular carcinoma
Page 41 and 42: Table 1c. Hepatocellular carcinoma
Page 43 and 44: Table 2a. Hepatic metastases from c
Page 45: Appendix 3 Ref nr Study Reason for

M Rizell, R Hultborn, P Bernhardt, J Svensson, M Sternby Eilard, O ...

Create successful ePaper yourself

Delete template?

Save as template?